Recent studies have reported that TWF1 has a close association with breast cancer, and miR-30c has been proposed to directly target TWF1, leading to inhibition of chemotherapy resistance and inhibit tumor invasion of human breast tumor (13, 25). Here, TWF1 is linked to neoplasm.